Nelson, Van Denburg & Campbell Wealth Management Group, LLC Bicycle Therapeutics PLC Transaction History
Nelson, Van Denburg & Campbell Wealth Management Group, LLC
- $2.63 Billion
- Q4 2024
A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 4,043 shares of BCYC stock, worth $44,594. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,043Holding current value
$44,594% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BCYC
# of Institutions
104Shares Held
42.9MCall Options Held
12.1KPut Options Held
17.4K-
Baker Bros. Advisors LP New York, NY10.9MShares$120 Million1.69% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.55MShares$50.2 Million0.15% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$38.1 Million8.16% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.61MShares$28.8 Million0.17% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$24.2 Million0.43% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $327M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...